Application for emergency use authorisation of Covid-19 antibody therapy (VIR-7831) filed in the US

The application is seeking its use to treat adults and adolescents >12 years weighing ≥40kg with mild-to-moderate COVID-19 who are at risk of being hospitalised due to severe illness which could also lead to death.

Source:

Reuters Health